Waters Corp. WAT

NYS: WAT | ISIN: US9418481035   22/04/2024
299,23 USD (+1,06%)
(+1,06%)   22/04/2024

22 april 2024 · Waters Accelerates the Development of Gene-based Therapeutics with New GTxResolve Premier SEC Columns · Persbericht

11 april 2024 · Waters Corporation Schedules First Quarter 2024 Earnings Conference Call · Persbericht

9 april 2024 · Waters Launches Alliance iS Bio HPLC System to Help Biopharma QC Labs Increase Efficiency and Reduce Errors · Persbericht

14 maart 2024 · Waters Streamlines and Expedites PFAS Testing with Innovative Oasis Dual-Phase Cartridges · Persbericht

13 maart 2024 · Waters Advances Battery Electrode Design and Performance Analysis with New Rheo-IS Accessory · Persbericht

26 februari 2024 · Waters Announces Seamless HPLC/UPLC Data Bridge for Light Scattering, Integrating Essential Instruments for Large Molecule Characterization · Persbericht

22 februari 2024 · Waters Corporation to Present at the TD Cowen 44th Annual Health Care Conference · Persbericht

6 februari 2024 · Waters Corporation (NYSE: WAT) Reports Fourth Quarter and Full-Year 2023 Financial Results · Persbericht

18 januari 2024 · Waters Corporation Schedules Fourth Quarter 2023 Earnings Conference Call · Persbericht

21 december 2023 · Waters Corporation to Present at the 42nd Annual J.P. Morgan Healthcare Conference · Persbericht

19 december 2023 · Waters Earns Sustainability Designation from My Green Lab for Xevo TQ Absolute System · Persbericht

19 december 2023 · Waters Corporation Named to Dow Jones Sustainability Index for the Third Consecutive Year · Persbericht

18 december 2023 · Waters Corporation Board of Directors Named 2024 Public Company Board of the Year by National Association of Corporate Directors New England Chapter · Persbericht

6 december 2023 · Waters Corporation Opens New State-of-the-Art Global Capability Center in Bengaluru, India · Persbericht

5 december 2023 · Waters Earns Top Score in Human Rights Campaign Foundation's 2023-2024 Corporate Equality Index · Persbericht

7 november 2023 · Waters Corporation (NYSE: WAT) Reports Third Quarter 2023 Financial Results · Persbericht

24 oktober 2023 · Waters Corporation Announces Business Unit Leadership Transition · Persbericht

19 oktober 2023 · Waters Accelerates Oligonucleotide Bioanalysis with the Launch of OligoWorks™ SPE Workflow and Kits · Persbericht

10 oktober 2023 · Waters Corporation Schedules Third Quarter 2023 Earnings Conference Call · Persbericht

20 september 2023 · L'instrument ZetaStar de Waters augmente la vitesse et la sensibilité des mesures de diffusion de la lumière pour les thérapies biologiques · Persbericht

Mijn selecties